NCT01063218

Evaluation of Cetaphil Advanced Usage to Control Light to Moderate Atopic Dermatitis, in Attempt to Reduce the Necessity of Topic Corticoids Application

Phase IV - Evaluation of Cetaphil Advanced Usage to Control Light to Moderate Atopic Dermatitis, in Attempt to Reduce the Necessity of Topic Corticoids Application

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 74 (estimated)
• Sponsor: Galderma Brasil Ltda. · Industry
• Sex: All
• Age: 2 Years – 10 Years
• Healthy volunteers: Accepted

Summary

The main goal of this present study is evaluate the decreasing of necessity of topic corticoids usage to control outbreaks of light to moderate atopic dermatitis by using the correct emollients.

Conditions

• Dermatitis, Atopic

Interventions

Type	Name	Description
OTHER	Emollient - Cetaphil Advanced	Emollient - Cetaphil Advanced - to be applied twice a day for 20 weeks.

Timeline

• Start date: 2009-12-01
• Primary completion: 2010-09-01
• Completion: 2010-10-01
• First posted: 2010-02-05
• Last updated: 2012-03-12

Locations

2 sites across 1 country: Brazil